期刊文献+

下调miR-146a对树突状细胞诱导的抗胰腺癌免疫反应的影响 被引量:2

原文传递
导出
摘要 胰腺癌恶性程度较高,传统治疗不能明显提高患者的5年生存率。因此,以肿瘤免疫及相关机制为对象的研究成为目前实现胰腺癌有效治疗的重要手段。本实验以胰腺癌细胞上清液(Pancreaticcancer.ConditionedMedium,Pc—CM)模拟体内肿瘤微环境,联合人源化裸鼠模型,体内外观察下调miR-146a对树突状细胞(dendriticcell,DC)诱导的抗胰腺癌免疫反应的影响。
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2014年第9期686-688,共3页 Chinese Journal of Hepatobiliary Surgery
  • 相关文献

参考文献10

  • 1吴文川,靳大勇,楼文晖,戎叶飞,王单松,秦新裕.新型胰腺癌MUC1DNA疫苗的免疫原性研究[J].中华肝胆外科杂志,2013,19(3):212-214. 被引量:2
  • 2王天笑,徐建威,郑连芳,万世奇,张太平,赵玉沛.抗表皮生长因子受体单链抗体联合放化疗治疗裸鼠移植胰腺癌的研究[J].中华肝胆外科杂志,2013,19(4):291-295. 被引量:3
  • 3Tan G,Wang Z,Zhang X,et al.Induction of CTLs by DCs pulsed with K-ras mutant peptide on the surface of nanoparticles in the treatment of pancreatic cancer[J].Oncol Rep,2011,26(1):215-221.
  • 4Coventry B,Heinzel S.CD1a in human cancers:a new role for an old molecule[J].Trends Immunol,2004,25(5):242-248.
  • 5Bellone G,Carbone A,Smirne C,et al.Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells[J].J Immunol,2006,177 (5):3448-3460.
  • 6Williams AE,Perry MM,Moschos SA,et al.Role of miRNA 146a in the regulation of the innate immune response and cancer[J].Biochem Soc Trans,2008,36(6):1211-1215.
  • 7Karrich JJ,Jachimowski LC,Libouban M,et al.MicroRNA-146a regulates survival and maturation of human plasmacytoid dentirtic cells[J].Blood,2013,122(17):3001-3009.
  • 8刘长征,刘卫,李静静,郑毅,于岚,何小东,陈松森.肝内及肝外胆管癌组织表达上调microRNAs表达谱的鉴定[J].中华肝胆外科杂志,2012,18(6):466-469. 被引量:5
  • 9Donners MM,Beckers L,Lievens D,et al.The CD40-TRAF6 ax is is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling[J].Blood,2008,111 (9):4596-4604.
  • 10Robson NC,Phillips DJ,McAlpine T,et al.A novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production[J].Blood,2008,111 (5):2733-2743.

二级参考文献33

  • 1吴文川,靳大勇,秦新裕,楼文晖,王单松,倪晓凌,吴肇汉.胰腺癌MUC1-VNTR核酸疫苗的构建和体外转染[J].中华实验外科杂志,2005,22(9):1081-1083. 被引量:9
  • 2吴文川,靳大勇,秦新裕,楼文晖,王单松,倪晓凌,吴肇汉.建立胰腺癌黏液蛋白核芯肽-连续重复序列核酸疫苗的实验研究[J].中华普通外科杂志,2006,21(5):357-359. 被引量:7
  • 3Ambros V. microRNAs: tiny regulators with great potential [J]. Cell, 2001, 107: 823-826.
  • 4Lee RC, Feinbaum RL, Ambros V. The C. elegans hetero- chronic gene lin-4 encodes small RNAs with antisense comple mentarity to lin 14[J]. Cell, 1993, 75: 843-854.
  • 5Liu C, Yu J, Yu S, et al. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma [J]. J Hepatol, 2010, 53:98-107.
  • 6Lu J, Getz G, Miska EA, et al. MieroRNA expression profiles classify human cancers[J]. Nature, 2005, 435 (7043) : 834-838.
  • 7Friman S. Cholangiocarcinoma-current treatment options[J]. Scand J Surg, 2011, 100: 30-34.
  • 8Perrotti D, Eiring AM. The new role of microRNAs in cancer [J]. Future Oncol, 2010, 6:1203-1206.
  • 9Kota J, Chivukula RR, O'Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model[J]. Cell, 2009, 137:1005-1017.
  • 10Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells[J]. Cancer Res, 2005, 65: 6029-6033.

共引文献7

同被引文献26

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部